Prices for new drugs approved for use in the treatment of cancer in the United States more than doubled over the past decade, according to an analysis published Thursday by JAMA Oncology.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,